$ITCI
Intra-Cellular Therapies, Inc.

2015 Q4 Form 10-Q Financial Statement

#000119312515368374 Filed on November 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $30.66K $0.00 $124.4K
YoY Change -53.45% -100.0% -81.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.540M $3.890M $2.580M
YoY Change 75.81% 50.78% 98.46%
% of Gross Profit
Research & Development $22.87M $28.46M $4.046M
YoY Change 96.48% 603.29% -2.68%
% of Gross Profit
Depreciation & Amortization $50.00K $40.00K $6.409K
YoY Change 400.0% 524.12% 35.53%
% of Gross Profit
Operating Expenses $29.40M $32.35M $4.046M
YoY Change 91.41% 699.47% -2.68%
Operating Profit -$32.35M -$6.504M
YoY Change 397.41% 35.91%
Interest Expense $540.0K $190.0K
YoY Change 440.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$28.83M -$32.16M -$6.420M
YoY Change 89.67% 400.94% 30.75%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$28.83M -$32.16M -$6.416M
YoY Change 89.71% 401.29% 30.62%
Net Earnings / Revenue -94049.11% -5156.58%
Basic Earnings Per Share
Diluted Earnings Per Share -$668.4K -$910.5K -$218.5K
COMMON SHARES
Basic Shares Outstanding 43.02M shares 35.06M shares 29.39M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $475.2M $510.7M $136.0M
YoY Change 266.67% 275.51% 195.01%
Cash & Equivalents $47.16M $332.8M $68.92M
Short-Term Investments $428.0M $177.9M $67.10M
Other Short-Term Assets $8.000M $1.500M $1.400M
YoY Change 515.38% 7.14% 75.0%
Inventory
Prepaid Expenses
Receivables $30.66K $0.00 $124.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $483.3M $512.3M $137.5M
YoY Change 268.94% 272.61% 191.71%
LONG-TERM ASSETS
Property, Plant & Equipment $775.5K $785.5K $57.44K
YoY Change 1321.59% 1267.59% -24.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $71.88K $71.88K $70.94K
YoY Change 1.31% 1.31% -45.74%
Total Long-Term Assets $847.4K $857.4K $128.4K
YoY Change 575.23% 567.86% -37.82%
TOTAL ASSETS
Total Short-Term Assets $483.3M $512.3M $137.5M
Total Long-Term Assets $847.4K $857.4K $128.4K
Total Assets $484.1M $513.1M $137.6M
YoY Change 269.23% 272.88% 190.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.633M $705.0K $503.9K
YoY Change -20.45% 39.92% -87.49%
Accrued Expenses $4.600M $9.700M $3.100M
YoY Change -45.88% 212.9% -6.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.264M $10.39M $3.578M
YoY Change -40.67% 190.33% -53.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.600M $900.0K
YoY Change
Total Long-Term Liabilities $1.597M $900.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.264M $10.39M $3.578M
Total Long-Term Liabilities $1.597M $900.0K $0.00
Total Liabilities $7.861M $11.27M $3.600M
YoY Change -25.54% 213.0% -53.85%
SHAREHOLDERS EQUITY
Retained Earnings -$193.0M -$164.2M -$73.06M
YoY Change 118.74% 124.78% 47.52%
Common Stock $669.9M $666.1M $2.940K
YoY Change 220.65% 22655958.71% 32.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $476.2M $501.9M $134.0M
YoY Change
Total Liabilities & Shareholders Equity $484.1M $513.1M $137.6M
YoY Change 269.23% 272.88% 190.71%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$28.83M -$32.16M -$6.416M
YoY Change 89.71% 401.29% 30.62%
Depreciation, Depletion And Amortization $50.00K $40.00K $6.409K
YoY Change 400.0% 524.12% 35.53%
Cash From Operating Activities -$35.06M -$20.51M -$4.420M
YoY Change 464.57% 364.03% -7.14%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$110.0K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$250.9M -$45.48M -$17.84M
YoY Change 17323.61% 154.93%
Cash From Investing Activities -$250.9M -$45.58M -$17.84M
YoY Change 17326.39% 155.49% 89100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $345.2M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 320.0K 327.5M 30.00K
YoY Change 357.14% 1091600.0% -99.93%
NET CHANGE
Cash From Operating Activities -35.06M -20.51M -4.420M
Cash From Investing Activities -250.9M -45.58M -17.84M
Cash From Financing Activities 320.0K 327.5M 30.00K
Net Change In Cash -285.7M 261.4M -22.23M
YoY Change 3668.87% -1275.98% -162.2%
FREE CASH FLOW
Cash From Operating Activities -$35.06M -$20.51M -$4.420M
Capital Expenditures -$40.00K -$110.0K $0.00
Free Cash Flow -$35.02M -$20.40M -$4.420M
YoY Change 463.93% 361.54% -6.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Share Price
SharePrice
17.50
CY2014Q1 itci Net Proceeds From Public Offering
NetProceedsFromPublicOffering
115400000
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43022553 shares
CY2015Q1 itci Net Proceeds From Public Offering
NetProceedsFromPublicOffering
121800000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68915333
CY2015Q1 itci Area Of Office Space Leased
AreaOfOfficeSpaceLeased
16753 sqft
CY2015Q3 us-gaap Share Price
SharePrice
43.50
CY2015Q3 itci Net Proceeds From Public Offering
NetProceedsFromPublicOffering
327400000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2876069 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.42
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43009886 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
12.42
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1387369 shares
CY2015Q3 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1.00 pure
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43009886 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.96
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2876069 shares
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
666083825
CY2015Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1106620
CY2015Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8575333
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
501854170
CY2015Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
881143
CY2015Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
20000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
705043
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164214582
CY2015Q3 us-gaap Liabilities
Liabilities
11268139
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
513122309
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
4301
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2309806
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10386996
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19374
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71875
CY2015Q3 us-gaap Assets
Assets
513122309
CY2015Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
39000
CY2015Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
204734000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
785544
CY2015Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
177903693
CY2015Q3 us-gaap Assets Current
AssetsCurrent
512264890
CY2015Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
16800000
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1532908
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
332828289
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3095350
CY2015Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
177923000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35150924
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2233460 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.20
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29499059 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29499059 shares
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
208912345
CY2014Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
975058
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7529241
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
120554705
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2052765
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88255957
CY2014Q4 us-gaap Liabilities
Liabilities
10557064
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
131111769
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2950
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2228413
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10557064
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-104633
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
70944
CY2014Q4 us-gaap Assets
Assets
131111769
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
106000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-211904
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15559719
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-67389
us-gaap Investment Income Interest
InvestmentIncomeInterest
204396
us-gaap Share Based Compensation
ShareBasedCompensation
2192860
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
16201092
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
33764409
us-gaap Interest Expense
InterestExpense
7073
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-65286459
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
26994790
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
115651683
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
us-gaap Net Income Loss
NetIncomeLoss
-15492330
CY2014Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
115815000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51603
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54553
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
68320672
CY2014Q4 us-gaap Assets Current
AssetsCurrent
130986272
CY2014Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
8500000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1288953
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61325044
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2282966
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
68425000
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7063300 shares
CY2014Q1 itci Share Issued During Period Shares Underwriters New Issues
ShareIssuedDuringPeriodSharesUnderwritersNewIssues
921300 shares
CY2015Q1 itci Share Issued During Period Shares Underwriters New Issues
ShareIssuedDuringPeriodSharesUnderwritersNewIssues
661481 shares
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7935000 shares
CY2015Q3 itci Share Issued During Period Shares Underwriters New Issues
ShareIssuedDuringPeriodSharesUnderwritersNewIssues
1035000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16600815
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022 pure
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28386794 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8324
us-gaap Revenues
Revenues
511439
us-gaap Interest Paid
InterestPaid
7073
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
551524
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
748538
us-gaap Operating Income Loss
OperatingIncomeLoss
-15689653
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
92272925
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-144017
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9585336
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
116191285
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-365251
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-67224332
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
99103
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6615756
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
131538
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2891185
us-gaap Depreciation
Depreciation
19156
itci Proceeds From Common Stock Subscribed
ProceedsFromCommonStockSubscribed
109833
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018 pure
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.25
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001567514
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y1M6D
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
449569252
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Cash equivalents and certificates of deposits are held with major financial institutions in the United States. Certificates of deposit held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk.</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.99
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although actual results could differ from those estimates, management does not believe that such differences would be material.</p> </div>
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
159864 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
19.04
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Intra-Cellular Therapies, Inc.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
13500 shares
dei Trading Symbol
TradingSymbol
ITCI
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33716032 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
815973 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
823585
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
us-gaap Net Income Loss
NetIncomeLoss
-75958625
us-gaap Revenues
Revenues
60705
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
244886
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
745143
us-gaap Operating Income Loss
OperatingIncomeLoss
-76441040
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
231146274
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-520328
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-51603
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75873366
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
85259
us-gaap Investment Income Interest
InvestmentIncomeInterest
482415
us-gaap Share Based Compensation
ShareBasedCompensation
7466595
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
76501745
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
271503245
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
881143
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-110841675
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
121128184
itci Available For Sale Securities Maturity Period
AvailableForSaleSecuritiesMaturityPeriod
More than three months
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64852576
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
449996887
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1177654
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
317508
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11649169
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
136984
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1347722
us-gaap Depreciation
Depreciation
92594
itci Share Based Compensation Arrangement By Share Based Payment Award Canceled Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceledWeightedAverageRemainingContractualTerm
P7Y8M12D
itci Maturity Period Of Liquid Investments To Be Considered As Cash Equivalents
MaturityPeriodOfLiquidInvestmentsToBeConsideredAsCashEquivalents
Three months or less
itci Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRemainingContractualTerm
P2Y8M12D
itci Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm2
P9Y3M18D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2014 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015Q1 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P11Y
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29379156 shares
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-6415507
CY2014Q3 us-gaap Revenues
Revenues
124414
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6503606
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6435147
CY2014Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-19640
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
88099
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1702645
CY2014Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6628020
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4046335
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2581685
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35320046 shares
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-32160483
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32349375
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32127180
CY2015Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
33303
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
188892
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2865990
CY2015Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
32349375
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28457631
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3891744

Files In Submission

Name View Source Status
0001193125-15-368374-index-headers.html Edgar Link pending
0001193125-15-368374-index.html Edgar Link pending
0001193125-15-368374.txt Edgar Link pending
0001193125-15-368374-xbrl.zip Edgar Link pending
d24660d10q.htm Edgar Link pending
d24660dex101.htm Edgar Link pending
d24660dex311.htm Edgar Link pending
d24660dex312.htm Edgar Link pending
d24660dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
itci-20150930.xml Edgar Link completed
itci-20150930.xsd Edgar Link pending
itci-20150930_cal.xml Edgar Link unprocessable
itci-20150930_def.xml Edgar Link unprocessable
itci-20150930_lab.xml Edgar Link unprocessable
itci-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending